|
|
||||||||
The Journal of Immunology, Vol 149, Issue 1 113-119, Copyright © 1992 by American Association of Immunologists
ARTICLES |
MP Colombo, L Lombardi, A Stoppacciaro, C Melani, M Parenza, B Bottazzi and G Parmiani
Division of Experimental Oncology D, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milano, Italy.
We have previously demonstrated that the murine colon adenocarcinoma C- 26 cell line transduced with the human gene for the granulocyte CSF (G- CSF) loses tumorigenic activity through a mechanism that involved massive targeting of neutrophils at the site of tumor injection. The suppression of tumorigenicity by G-CSF was limited to the G-CSF- producing cells and was not transferred to nonproducing C-26 cells in a mixed tumor transplantation assay. We present direct evidence that neutrophils are involved in this phenomenon. We firstly examined, by electron microscopy (EM), the morphology of tumor infiltrates obtained 2, 5, and 10 days after s.c. injection of a mixture of G-CSF-producing and -nonproducing C-26 cells into syngeneic BALB/c mice. The EM analysis showed at 5, but not at 2 or 10 days, the presence of neutrophils in intimate contact with tumor cells. We then investigated whether neutrophils discriminate between G-CSF-producing and - nonproducing C-26 cells. To this aim, C-26 cells were transduced, via retroviral vector, with the Escherichia coli LacZ gene and mixed tumor transplantation assays were performed by injecting a mixture of G-CSF- producing beta-gal- and G-CSF-nonproducing beta-gal+ C-26 cells at different ratios. Histologic and EM analysis of the tumors growing at the site of injection were carried out. Five days after injection, treatment with x-gal revealed, at the histochemical level, the presence of neutrophils around G-CSF producing beta-gal- cells; cell-cell contacts and fusion of cell membranes were detected by EM only between neutrophils and G-CSF-producing cells. In vitro experiments, performed in Boyden chambers, confirmed that the G-CSF produced by C-26 cells was a chemoattractant for neutrophils. In addition, a colorimetric, cytostatic assay revealed that neutrophils were able to inhibit the growth of G-CSF-producing but not of G-CSF-nonproducing C-26 cells. Thus the tumor take after injection of G-CSF-producing C-26 cells seems to be controlled in situ through two major mechanisms namely neutrophil chemotaxis and neutrophil-mediated tumor inhibition. The results indicate that neutrophils can discriminate between G-CSF-producing and - nonproducing tumor cells and that neutrophils infiltrate the tumor mixture as long as G-CSF-producing cells are present.
This article has been cited by other articles:
![]() |
T. Yamano, E. Morii, J.-I. Ikeda, and K. Aozasa Granulocyte Colony-stimulating Factor Production and Rapid Progression of Gastric Cancer after Histological Change in the Tumor Jpn. J. Clin. Oncol., October 1, 2007; 37(10): 793 - 796. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okazaki, S. Ebihara, M. Asada, A. Kanda, H. Sasaki, and M. Yamaya Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models Int. Immunol., January 1, 2006; 18(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Grote, R. Cattaneo, and A. K. Fielding Neutrophils Contribute to the Measles Virus-induced Antitumor Effect: Enhancement by Granulocyte Macrophage Colony-stimulating Factor Expression Cancer Res., October 1, 2003; 63(19): 6463 - 6468. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. van Spriel, H. H. van Ojik, A. Bakker, M. J. H. Jansen, and J. G. J. van de Winkel Mac-1 (CD11b/CD18) is crucial for effective Fc receptor-mediated immunity to melanoma Blood, January 1, 2003; 101(1): 253 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Cairns, J. R. Gordon, F. Li, M. E. Baca-Estrada, T. Moyana, and J. Xiang Lymphotactin Expression by Engineered Myeloma Cells Drives Tumor Regression: Mediation by CD4+ and CD8+ T Cells and Neutrophils Expressing XCR1 Receptor J. Immunol., July 1, 2001; 167(1): 57 - 65. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Di Carlo, G. Forni, P. Lollini, M. P. Colombo, A. Modesti, and P. Musiani The intriguing role of polymorphonuclear neutrophils in antitumor reactions Blood, January 15, 2001; 97(2): 339 - 345. [Full Text] [PDF] |
||||
![]() |
E. Di Carlo, A. Comes, S. Basso, A. De Ambrosis, R. Meazza, P. Musiani, K. Moelling, A. Albini, and S. Ferrini The Combined Action of IL-15 and IL-12 Gene Transfer Can Induce Tumor Cell Rejection Without T and NK Cell Involvement J. Immunol., September 15, 2000; 165(6): 3111 - 3118. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Vicari, S. Ait-Yahia, K. Chemin, A. Mueller, A. Zlotnik, and C. Caux Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms J. Immunol., August 15, 2000; 165(4): 1992 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Tagliabue, F. Castiglioni, C. Ghirelli, M. Modugno, L. Asnaghi, G. Somenzi, C. Melani, and S. Menard Nerve Growth Factor Cooperates with p185HER2 in Activating Growth of Human Breast Carcinoma Cells J. Biol. Chem., February 25, 2000; 275(8): 5388 - 5394. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimizu, A. Fontana, Y. Takeda, H. Yagita, T. Yoshimoto, and A. Matsuzawa Induction of Antitumor Immunity with Fas/APO-1 Ligand (CD95L)-Transfected Neuroblastoma Neuro-2a Cells J. Immunol., June 15, 1999; 162(12): 7350 - 7357. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fioretti, D. Fradelizi, A. Stoppacciaro, S. Ramponi, L. Ruco, A. Minty, S. Sozzani, C. Garlanda, A. Vecchi, and A. Mantovani Reduced Tumorigenicity and Augmented Leukocyte Infiltration After Monocyte Chemotactic Protein-3 (MCP-3) Gene Transfer: Perivascular Accumulation of Dendritic Cells in Peritumoral Tissue and Neutrophil Recruitment Within the Tumor J. Immunol., July 1, 1998; 161(1): 342 - 346. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Noffz, Z. Qin, M. Kopf, and T. Blankenstein Neutrophils but Not Eosinophils Are Involved in Growth Suppression of IL-4-Secreting Tumors J. Immunol., January 1, 1998; 160(1): 345 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gojo, S. Kitamura, O. Hatano, A. Takakusu, K. Hashimoto, Y. Kanegae, and I. Saito TRANSPLANTATION OF GENETICALLY MARKED CARDIAC MUSCLE CELLS J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 10 - 18. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |